Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-23-021131

Options or other derivatives

  • CEO, CFO, Director acquired 215,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Finley John David · CEO, CFO, Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-06-11 Grant or award : show line 1 in the form Restricted Stock Units +66,700 66,700 D
2023-06-11 Grant or award : show line 2 in the form Common Stock Options +148,500 148,500 D
Loading xslF345X04/ownership.xml…